Indian medical devices & diagnostic sector expects several key …
Jan 20, 2025 · Indian medical devices & diagnostic sector expects several key measures in Budget 2025 to reduce import dependence
Zydus Lifesciences announces financial results for the quarter and …
Zydus Lifesciences announces financial results for the quarter and nine months ended Dec 31, 2024: Our Bureau, Mumbai Thursday, February 6, 2025, 16:30 Hrs [IST]
Industry experts outline critical reforms for resilient, inclusive ...
Jan 17, 2025 · Industry experts outline critical reforms for resilient, inclusive healthcare & pharma sector in Union Budget 2025-26
India's most comprehensive portal on pharmaceutical News, …
Feb 12, 2025 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
US FDA approves AstraZeneca & Daiichi Sankyo’s Enhertu to treat …
Jan 29, 2025 · US FDA approves AstraZeneca & Daiichi Sankyo’s Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies
Innovent Biologics receives China NMPA breakthrough therapy …
Jan 17, 2025 · Innovent Biologics receives China NMPA breakthrough therapy designation for IBI343 as monotherapy for advanced pancreatic cancer
In 2024 EMA recommends 114 medicines for marketing …
Jan 18, 2025 · In 2024 EMA recommends 114 medicines for marketing authorisation; 46 had a new active substance: Amsterdam, The Netherlands Saturday, January 18, 2025, 13:00 Hrs [IST]
Glenmark Life Sciences rebrands as Alivus Life Sciences
Jan 18, 2025 · Glenmark Life Sciences rebrands as Alivus Life Sciences: Our Bureau, Mumbai Saturday, January 18, 2025, 15:45 Hrs [IST] Glenmark Life Sciences, a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas, announces its change of identity to Alivus Life Sciences, marking an exciting new chapter in its journey.
InflaRx receives European marketing authorization for Gohibicto …
Jan 17, 2025 · InflaRx N.V., a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced that the European Commission (EC) has granted marketing authorization under exceptional circumstances for Gohibic (vilobelimab) for the treatment of adult patients with SARS ...
Pliant Therapeutics voluntarily paused enrollment and dosing in …
Feb 10, 2025 · Pliant Therapeutics voluntarily paused enrollment and dosing in ongoing BEACON-IPF phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis